Team:St Andrews/Omega-3-synthesis
From 2012.igem.org
(spanlength for primers) |
(mini buttons for primers) |
||
Line 292: | Line 292: | ||
<div class="btn-toolbar"> | <div class="btn-toolbar"> | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 T. Cruzi forward | Δ12 T. Cruzi forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 302: | Line 302: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 T. Cruzi reverse | Δ12 T. Cruzi reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 312: | Line 312: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 Synechocystis forward | Δ12 Synechocystis forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 322: | Line 322: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 Synechocystis reverse | Δ12 Synechocystis reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 332: | Line 332: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ15 Synechocystis forward | Δ15 Synechocystis forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 345: | Line 345: | ||
<div class="btn-toolbar"> | <div class="btn-toolbar"> | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ15 Synechocystis reverse | Δ15 Synechocystis reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 355: | Line 355: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ6 Synechocystis forward | Δ6 Synechocystis forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 365: | Line 365: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ6 Synechocystis reverse | Δ6 Synechocystis reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 375: | Line 375: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
ELO6 L. major forward | ELO6 L. major forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 385: | Line 385: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
ELO6 L. major reverse | ELO6 L. major reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 402: | Line 402: | ||
<div class="btn-toolbar"> | <div class="btn-toolbar"> | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
ELO6 L. major forward | ELO6 L. major forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 412: | Line 412: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ15 T. Cruzi forward | Δ15 T. Cruzi forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 422: | Line 422: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ6 T. Cruzi forward | Δ6 T. Cruzi forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 432: | Line 432: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ6 T. Cruzi reverse | Δ6 T. Cruzi reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 442: | Line 442: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 T. Cruzi forward | Δ12 T. Cruzi forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 452: | Line 452: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ12 T. Cruzi reverse | Δ12 T. Cruzi reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 466: | Line 466: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ9 T. Cruzi reverse | Δ9 T. Cruzi reverse | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 476: | Line 476: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ15 T. Cruzi forward | Δ15 T. Cruzi forward | ||
<span class="caret"></span> | <span class="caret"></span> | ||
Line 486: | Line 486: | ||
<div class="btn-group"> | <div class="btn-group"> | ||
- | <a class="btn dropdown-toggle" data-toggle="dropdown" href="#"> | + | <a class="btn btn-mini dropdown-toggle" data-toggle="dropdown" href="#"> |
Δ15 and Δ12 T. Cruzi reverse | Δ15 and Δ12 T. Cruzi reverse | ||
<span class="caret"></span> | <span class="caret"></span> |
Revision as of 11:58, 23 September 2012
Omega-3 fatty acid synthesis
Introduction
ω-3 Fatty acids are an essential component of our diet and are paramount to maintaining human health. Our team is recreating this synthetic pathway in E. coli, using genes from the cyanobacteria Synechocystis and the trypanosomatid Leishmania major. Combining the DNA code for elongase and desaturase enzymes, we can convert the plain fatty acid of E. coli into highly valuable ω-3 fatty acids.
Project Description
-
Synechocystis sp. -
Trypanosome cruzi -
Leishmania major
Omega-3 fatty acids are an essential part of the human diet (Bender, Bender, 1999). Human beings, as all larger organisms, cannot synthesize ω-3 fatty acids, This is due to a lack of the enzyme Δ15 desaturase, which creates a double bond at the 15th carbon of a long-chain fatty acid. Certain microrganisms, such as microalgae and cyanobacteria, do contain this desaturase and can thus directly synthesize ω-3 fatty acids (Arts et al, 2009). ω-3 fatty acids then enter the food chain – algae are eaten by fish, and seafood is sbsequently the main source of ω-3 for humans(Tonon et al, 2002).
However, the current economic policies of overfishing are a serious contributor to marine biodestruction. As the human population is estimated to rise to 9.1 billion by 2050 (Cohen, 2003), pressure on fish stock will increase. Additionally, global warming will reduce the availability of ω-3 (Arts et al, 2009): at higher temperatures, microalgae produce less ω-3 desaturated fatty acids. Desaturated carbon chains cause a lower melting temperature in the membrane, which the microorganism wants to avoid by synthesizing more saturated fatty acids in their membranes (Garwin, Cronan, 1980). Thus, the combination of declining fish stock and a decrease in overall ω-3 fatty acids is making the supply for human nutrition a relevant issue.
Harvesting algae directly is costly and ineffective (Borowitzka, 1997). There is much potential in expressing a metabolic pathway for ω-3 fatty acid synthesis in E. coli, which is cheaper and more accessible.
Synthesizing the pathway
-
Figure 1 showing the elongation and desaturation enzymes necessary to convert an 18:1 fatty acid, which E. coli synthesizes, into an poly-unsaturated fatty acid. modified from Livore et al, 2006
E. coli naturally synthesize poly-unsaturated fatty acids up to a carbon chain length of 18, with a single desaturation at the 9th carbon (18:1) (Marr, Ingraham, 1969). Valuable ω-3 fatty acids require 3 double bonds, and need to have a chain length between 18 and 22 carbons.
In order to have
synthesize ω-3 fatty acids, we needed to introduce enzymes that could elongate and desaturate fatty acid substrates. As seen in Fig. 1, this pathway can be recreated by a number of desaturases and elongases. The genes for Δ12, Δ15 (ω6) and Δ6 were obtained from Synechocystis sp., a cyanobacteria. The trypanosomatid Leishmania major provided the DNA for the ELO 6 gene. Additionally, we used Trypanosome cruzi as a secondary source of Δ12.
However, our first successful ligations of Δ12 did not yield us with the expected 18:2 fatty acid. We hypothesized that E. coli’s inherent 18-carbon chain fatty acid might not be suited as a substrate for Δ12 – perhaps the double bond is in a different position. Therefore, we “fed” our cells with suitable 18:1, to then observe 18:2 fatty acid in the mass spec results!
Methods
Sequences Primers Sequencing results Lipid analysis Mass Spectrometry
Sequences